Leading digital diagnostics company PocDoc on Thursday (24) announced partnership with advanced analytics firm IQVIA to help identify cardiovascular risk at scale and create more connected pathways between screening and care to improve survival rates.
While advances in cardiovascular therapeutics are creating new opportunities to prevent and treat disease, but their impact depends on finding the people who could benefit.
Identifying cardiovascular risk earlier and connecting patients into appropriate clinical pathways remains a critical part of that challenge.
PocDoc is building the digital infrastructure for cardiovascular disease prevention, enabling testing to move beyond traditional healthcare settings and reach people across primary care, pharmacy, community and workplace settings.
Its technology provides results in minutes and integrates them into digital care pathways, helping healthcare systems identify cardiovascular risk at scale.
PocDoc uses a finger prick blood test and smartphone app to provide a full cholesterol profile alongside heart age and cardiovascular risk in under ten minutes.
Its AI analyses an image of the test captured through a smartphone camera, helping people understand their results and connecting them with appropriate follow up and clinical pathways.
PocDoc's Healthy Heart Check has acquired a nationwide reach in less than three years after launch.
By combining PocDoc's screening infrastructure with IQVIA's expertise across healthcare data, technology, clinical research and commercialisation, the partnership will help healthcare systems and pharmaceutical companies develop, launch and scale cardiovascular treatment programmes faster and more efficiently.
PocDoc CEO and co-founder Steve Roest said: "Despite major advances in cardiovascular therapeutics, those advances can only make a difference if we identify the people at risk. That means making cardiovascular testing far more accessible and ensuring the results can connect into the wider healthcare system.
"IQVIA brings extensive expertise across life sciences, data and health systems, while PocDoc has built the digital infrastructure to make cardiovascular risk identification accessible at scale. Together, we can help close the gap between screening and care, and this is just the start of what that collaboration can do."
PocDoc is also planning to expand its platform into 11 European markets during 2026.
